Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Thorax 2006;61:93; doi:10.1136/thx.2006.awfeb06
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedzicha, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wedzicha, W.
Topic Collections
Right arrowRelevant Articles

Airwaves

Wisia Wedzicha, Editor in Chief

The first 150 words of the full text of this article appear below.


LUNG FUNCTION DECLINE IN ASTHMA
Although it is recognised that asthmatic subjects have an accelerated decline in lung function, factors affecting the long term outcome of asthma are still relatively unknown. In this issue of Thorax we report two studies and publish an editorial on this topic. Lange and colleagues describe the 10 year follow up of two groups of asthmatic subjects, one of which was treated with inhaled corticosteroids (ICS). After adjustment for other variables, treatment with ICS was associated with a significant reduction in the decline in forced expiratory volume in 1 second (FEV1), with a decline of 51 ml/year in patients not receiving treatment with ICS and 25 ml/year in the ICS group. In his editorial Ernst discusses the implications and limitations of this study and suggests that, although the effects of ICS on disease progression were evident in the group as a whole, the benefit may vary substantially between asthmatic . . . [Full text of this article]


Relevant Articles

Inhaled corticosteroids and decline of lung function in community residents with asthma
P Lange, H Scharling, C S Ulrik, and J Vestbo
Thorax 2006 61: 100-104. [Abstract] [Full Text] [PDF]

Why does airway inflammation persist after the smoking stops?
J C Hogg
Thorax 2006 61: 96-97. [Extract] [Full Text] [PDF]

Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex
A Dijkstra, J M Vonk, H Jongepier, G H Koppelman, J P Schouten, N H T ten Hacken, W Timens, and D S Postma
Thorax 2006 61: 105-110. [Abstract] [Full Text] [PDF]

Relation between duration of smoking cessation and bronchial inflammation in COPD
T S Lapperre, D S Postma, M M E Gosman, J B Snoeck-Stroband, N H T ten Hacken, P S Hiemstra, W Timens, P J Sterk, T Mauad on behalf of the GLUCOLD Study Group
Thorax 2006 61: 115-121. [Abstract] [Full Text] [PDF]

Inhaled corticosteroids moderate lung function decline in adults with asthma
P Ernst
Thorax 2006 61: 93-94. [Extract] [Full Text] [PDF]

Improving rate of decline of FEV1 in young adults with cystic fibrosis
C Que, P Cullinan, and D Geddes
Thorax 2006 61: 155-157. [Abstract] [Full Text] [PDF]

Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects
M Malerba, F Ricciardolo, A Radaeli, C Torregiani, L Ceriani, E Mori, M Bontempelli, C Tantucci, and V Grassi
Thorax 2006 61: 129-133. [Abstract] [Full Text] [PDF]

Inhalation of stable dust extract prevents allergen induced airway inflammation and hyperresponsiveness
M Peters, M Kauth, J Schwarze, C Körner-Rettberg, J Riedler, D Nowak, C Braun-Fahrländer, E von Mutius, A Bufe, O Holst the ALEX Study Group
Thorax 2006 61: 134-139. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society